Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 3, 1999, Pages 202-214

  Fletcher, Linda M ^a,b   Halliday, June W ^a   Powell, Lawrie W ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Alcohol; Ferritin; Haemochromatosis; Iron overload; Transferrin

Indexed keywords

ALCOHOL; FERRITIN; FREE RADICAL; IRON; IRON BINDING PROTEIN; TRANSFERRIN;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HEMOCHROMATOSIS; HEMOSIDEROSIS; HEPATITIS C; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; LIVER TOXICITY; OXIDATIVE STRESS; PATHOGENESIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

EID: 0032943924     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01836.x     Document Type: Review

References (157)

1. 1 Friedman S. Acetaldehyde and alcoholic fibrinogenesis: Fuel to the fire, but not the spark. Hepatology 1990; 12: 609-11.
2. 2 Britton RS. Metal-induced hepatotoxicity. Semin. Liver Dis. 1996; 16: 3-12.
3. 3 Harrison PM, Andrews SC, Artymuik PJ et al. Probing structure-function relations in ferritin and bacterioferritin. Adv. Inorg. Chem. 1991; 36: 449-86.
4. 4 Harrison PM, Clegg GA, May K. Iron in Biochemistry and Medicine II. London: Academic Press, 1980.
5. 5 Massover WH. Ultrastructure of ferritin and apoferritin: A review. Micron 1993; 24: 389-437.
6. 6 Munro HN, Linder MC. Ferritin: Structure, biosynthesis and role in iron metabolism. Physiol. Rev. 1978; 58: 317-96.
7. 7 Worwood M. Ferritin. Blood Rev. 1990; 4: 259-69.
8. 8 Leibold EA, Munro HN. Characterization and evolution of the expressed rat ferritin light subunit gene and its pseudogene family. J. Biol. Chem. 1987; 262: 7335-41.
9. 9 Harrison PM, Ford GC, Rice DW, Smith JMA, Treffry A, White JL. The three dimensional structure of apoferritin: A framework controlling ferritin's iron storage and release. In: Xavier AV, ed. Frontiers in Bioinorganic Chemistry. Weinheim: VCH, 1986; 268-77.
10. 10 Drysdale JW, Munro HN. Regulation of synthesis and turnover of ferritin in rat liver. J. Biol. Chem. 1966; 241: 3630-7.
11. 11 Lawson DM, Treffry A, Artymuik PJ et al. Identification of the ferroxidase centre in ferritin. FEBS Lett. 1989; 254: 207-10.
12. 12 Arosio P, Levi S, Santambrogio P et al. Structural and functional studies of human ferritin H and L chains. Curr. Stud. Hematol. Blood Transfus. 1991; 58: 127-31.
13. 13 Broxmeyer HE, Cooper S, Levi S, Arosio P. Mutated recombinant heavy-chain ferritins and myelosuppression in vitro and in vivo: A link between ferritin ferroxidase activity and biological function. Proc. Natl Acad. Sci. USA 1991; 88: 770-4.
14. 14 Santambrogio P, Levi S, Cozzi A, Corsi B, Arosio P. Evidence that the specificity of iron incorporation into homopolymers of human ferritin L-and H-chains is conferred by the nucleation and ferroxidase centres. Biochem. J. 1996; 314: 139-44.
15. 15 Mack U, Powell LW, Halliday JW. Detection and isolation of a hepatic membrane receptor for ferritin. J. Biol. Chem. 1983; 258: 4672-5.
16. 16 Moss D, Fargion S, Francanzani AL et al. Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J. Inorg. Biochem. 1992; 47: 219-27.
17. 17 Moss D, Powell LW, Arosio P, Halliday JW. Characterization of the ferritin receptors of human T lymphoid (MOLT-4) cells. J. Lab. Clin. Med. 1992; 119: 273-9.
18. 18 Gelvan D, Fibach E, Meyron-Holtz EG, Konijn AM. Ferritin uptake by human erythroid precursors is a regulated iron uptake pathway. Blood 1996; 88: 3200-7.
19. 19 Drysdale J. Human ferritin gene expression. Prog. Nucl. Acid Res. Mol. Biol. 1988; 35: 127-55.
20. 20 Munro HN, Aziz N, Leibold EA et al. The ferritin genes, structure, function and regulation. Ann. NY Acad. Sci. 1988; 526: 113-23.
21. 21 Worwood M. An overview of iron metabolism at the molecular level. J. Intern. Med. 1989; 226: 381-91.
22. 22 Lebo RV, Kan YW, Cheung MC, Jain SK, Drysdale J. Human ferritin light chain sequences mapped to several assorted chromosomes. Hum. Genet. 1985; 71: 325-8.
23. 23 Worwood M, Cragg SJ, Wagstaff M, Jacobs A. Binding of human serum ferritin to concanavalin A. Clin. Sci. 1979; 56: 83-7.
24. 24 Linder MC, Schaffer JS, Hazegh-Azam M, Zhou CY, Tran TN, Nagel GN. Serum ferritin: Does it differ from tissue ferritin? J. Gastroenterol. Hepatol. 1996; 11: 1033-6.
25. 25 MacGillivray RTA, Mendez E, Shewale JG, Sinha SK, Lineback-Zins J, Brew K. The primary structure of human serum transferrin. J. Biol. Chem. 1983; 258: 3543-53.
26. 26 Bowman BH, Yang F, Adrian GS. Transferrin: Evolution and genetic regulation of expression. Adv. Genet. 1988; 25: 1-38.
27. 27 Anderson BF, Baker HM, Dodson EJ et al. Structure of human lactoferrin at 3.2Å resolution. Proc. Natl Acad. Sci. USA 1987; 84: 1769-73.
28. 28 Aisen P, Listowsky I. Iron transport and storage proteins. Ann. Rev. Biochem. 1980; 49: 357-93.
29. 29 Jolles J, Mauzurier J, Boutigue MH, Spik G, Montreuil J, Jolles P. The N-terminal sequence of human lactotransferrin: Its close homology with the aminoterminal regions of other transferrins. FEBS Lett. 1976; 69: 27-31.
30. 30 Aisen P. The two-sited nature of transferrin: Spectroscopic, thermodynamic and physiologic studies. Inorg. Chim. Acta 1983; 79: 80.
31. 31 Anderson BF, Baker HM, Norris GE, Rice DW, Baker EN. Structure of human lactoferrin: Crystallographic structure analysis and refinement at the 2.8 A resolution. J. Mol. Biol. 1989; 209: 711-34.
32. 32 Baker EN, Baker HM, Smith CA et al. Human melanotransferrin (p97) has only one functional iron-binding site. FEBS Lett. 1992; 298: 215-18.
33. 33 Yang F, Lum JB, McGill JR et al. Human transferrin: cDNA characterization and chromosomal localization. Proc. Natl Acad. Sci. USA 1984; 81: 2752-6.
34. 34 Schaeffer E, Lucero MA, Jeltsch J-M, Py M-C, Chambon P, Cohen GNA-Z. Complete structure of the human transferrin gene. Comparison with analogous chicken gene and human pseudogene. Gene 1987; 56: 109-16.
35. 35 Smithies O. Variations in human ß-globulins. Nature 1957; 180: 1482-3.
36. 36 deJong G, van Dijk JP, van Eijk HG.The biology of transferrin. Clin. Chim. Acta 1990; 190: 1-46.
37. 37 Marz L, Hatton MWC, Berry LR, Regoeczi E.The structural heterogeneity of the carbohydrate moiety of desialylated human transferrin. Can. J. Biochem. 1982; 60: 624-30.
38. 38 Spik G, Bayard B, Fournet B, Strecker G, Bouquelet S, Montreuil J. Studies on glycoconjugates LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett. 1975; 50: 296-9.
39. 1H-NMR nuclear Overhauser effect measurements. FEBS Lett. 1982; 150: 503-6.
40. 40 Fu D, Van Halbeek H. N-Glycosylation site mapping of human serotransferrin by serial lectin affinity chromatography, fast atom bombardment-mass spectrometry and H nuclear magnetic resonance spectroscopy. Anal. Biochem. 1992; 206: 53-63.
41. 41 Landberg E, Pahlsson P, Lundblad A, Arnetorp A, Jeppsson JO. Carbohydrate composition of serum ferritin isoforms from patients with high alcohol consumption. Biochem. Biophys. Res. Commun. 1995; 210: 267-74.
42. 42 Jeppsson JO, Kristensson H, Fimiani C. Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clin. Chem. 1993; 39: 215-20.
43. 43 Stibler H, Kjellin KG. Isoelectric focusing and electrophoresis of the CSF proteins in tremor of different origins. J. Neurol. Sci. 1976; 30: 269-85.
44. 44 Stibler H. Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed. Clin. Chem. 1991; 37: 2029-37.
45. 45 Fletcher LM, Kwoh-Gain I, Powell E, Powell LW, Halliday JW. Markers of chronic alcohol ingestion in patients with non-alcoholic steatohepatitis: An aid to diagnosis. Hepatology 1991; 13: 455-9.
46. 46 Allen JP, Litten RZ, Anton RF, Cross GM. Carbohydrate-deficient transferrin as a measure of immoderate drinking: Remaining issues. Alcohol. Clin. Exp. Res. 1994; 18: 799-812.
47. 47 Stibler H, Borg S. Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls. Scand. J. Clin. Lab. Invest. 1991; 51: 43-51.
48. 48 Xin Y, Lasker JM, Rosman AS, Lieber CS. Isoelectric focusing/western blotting: A novel and practical method for quantitation of carbohydrate-deficient transferrin in alcoholics. Alcohol. Clin. Exp. Res. 1991; 15: 814-21.
49. 49 Jacobs A. Iron overload - clinical and pathological aspects. Semin. Hematol. 1977; 14: 89-113.
50. 50 Finch C. Regulators of iron balance in humans. Blood 1994; 84: 1697-702.
51. 51 Aisen P. Entry of iron into cells: A new role for the transferrin receptor in modulating iron release from transferrin. Ann. Neurol. 1992; 32: S62-8.
52. 52 Aisen P. The physics and physiology of transferrin. Mt Sinai J. Med. 1970; 37: 213-22.
53. 53 Morgan E. Transferrin, biochemistry, physiology and clinical significance. Mol. Aspects Med. 1981; 4: 1-123.
54. 54 Heubers H, Finch C. Transferrin: Physiologic behavior and clinical implications. Blood 1984; 64: 763-7.
55. 55 Heubers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol. Rev. 1987; 67: 520-82.
56. 56 Klausner RD, Ashwell JV, VanRenswoude JB, Harford J, Bridges K. Binding of apotransferrin to K562 cells: Explanation of the transferrin cycle. Proc. Natl Acad. Sci. USA 1983; 80: 2263-6.
57. 57 Dautry-Varsat A, Ciehanover A, Lodish HF. pH and recycling of transferrin during receptor-mediated endocytosis. Proc. Natl Acad. Sci. USA 1983; 80: 2258-62.
58. 58 McClelland A, Kuhn LC, Ruddle FH.The human transferrin receptor gene: Genomic organisation and the complete primary structure of the receptor deduced from a cDNA sequence. Cell 1984; 39: 267-74.
59. 59 Saltman P. Oxidative stress: A radical view. Semin. Hematol. 1989; 26: 249-56.
60. 60 Ryan TP, Aust SD. The role of iron in oxygen-mediated toxicities. Crit. Rev. Toxicol. 1992; 22: 119-41.
61. 61 Iancu TC. Iron overload. Mol. Aspects Med. 1982; 6: 1-100.
62. 62 Iancu TC. Ferritin and hemosiderin in pathological tissues. Electron Micros. Rev. 1992; 5: 209-29.
63. 63 Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann. NY Acad. Sci. 1975; 252: 85-105.
64. 64 Sherlock S. Alcoholic liver disease. Lancet 1995; 345: 227-9.
65. 65 Day CP, Bassendine MF. Genetic predisposition to alcoholic liver disease. Gut 1992; 33: 1444-7.
66. 66 Lumeng L, Crabb DW. Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology 1994; 107: 572-8.
67. 67 Gilbert A, Grenet A. Cirrhose alcoholique hypertropique pigmentaire. La Semaine Med. 1896; 16: 514.
68. 68 Sheldon JH. Haemochromatosis. Oxford: Oxford University Press, 1935.
69. 69 MacDonald RA. Hemochromatosis and Hemosiderosis. Springfield IL: Thomas C, 1964.
70. 70 Simon M, Bourel M. Heredite de l'hemochromatose idiopathique demonstration de la transmission recessive et mise en evidene du gene responsable porte par le chromosome 6. Gastroenterol. Clin. Biol. 1978; 2: 573-7.
71. 71 Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 1976; 17: 332-4.
72. 72 Simon M, Fauchet R, Hespel JP et al. Idiopathic hemochromatosis: A study of biochemical expression in 247 heterozygous members of 63 families: Evidence for a single major HLA-linked gene. Gastroenterology 1980; 78: 703-8.
73. 73 Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy A. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 1996; 13: 399-408.
74. 74 Beutler E, Gelbert T, West C et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol. Dis. 1996; 22: 187-94.
75. 75 Jouanolle AM, Gandon G, Jezequel P et al. Haemochromatosis and HLA-H. Nature Genet. 1996; 14: 251-2.
76. 76 Jazwinska EC, Cullen LM, Busfield F et al. Haemochromatosis and HLA-H. Nature Genet. 1996; 14: 249-51.
77. 77 Beutler E. Genetic irony beyond haemochromatosis: Clinical effects of HLA-H mutations. Lancet 1997; 349: 296-7.
78. 78 Powell LW, Burt MJ, Halliday JW, Jazwinska EC. Haemochromatosis: Genetics and pathogenesis. Semin. Liver Dis. 1996; 16: 55-63.
79. 79 Eichner ER, Hillman RS. The evolution of anaemia in alcoholic patients. Am. J. Med. 1971; 50: 218-32.
80. 80 Krasner N, Cochran KM, Russel RI, Carmichael HA, Thompson GC. Alcohol and absorption from the small intestine. 1. Impairment of absorption from the small intestine in alcoholics. Gut 1976; 17: 245-8.
81. 81 Friedman IM, Kraemer HC, Mendoza FS, Hammer LD. Elevated serum iron concentration in adolescent alcohol users. Am. J. Dis. Child. 1988; 142: 156-8.
82. 82 Linderbaum J, Lieber CS. Hematologic effects of alcohol in man in the absence of nutritional deficiency. N. Engl. J. Med. 1969; 281: 333-8.
83. 83 Ford C, Wells FE, Rogers JN. Assessment of iron status in association with excess alcohol consumption. Ann. Clin. Biochem. 1995; 32: 527-31.
84. 84 Powell LW, Fletcher LM, Halliday JW. Distinction between haemochromatosis and alcoholic siderosis. In: Hall P, ed. Alcoholic Liver Disease: Pathology and Pathogenesis. London: Edward Arnold, 1995; 199-216.
85. 85 Chapman RWG, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic haemochromatosis. Dig. Dis. Sci. 1982; 27: 909-16.
86. 86 Chapman RW, Morgan MY, Bell R, Sherlock S. Hepatic iron uptake in alcoholic liver disease. Gastroenterology 1983; 84: 143-7.
87. 87 Chapman RW, Morgan MY, Boss AM, Sherlock S. Acute and chronic effects of alcohol on iron absorption. Dig. Dis. Sci. 1983; 28: 321-7.
88. 88 LeSage GD, Baldus WP, Fairbanks VF et al. Hemochromatosis: Genetic or alcohol induced? Gastroenterology 1983; 84: 1471-7.
89. 89 Bezwoda WR, Torrance JD, Bothwell TH, Macphail AP, Graham B, Mills W. Iron absorption from red and white wines. Scand. J. Haematol. 1985; 34: 121-7.
90. 90 Powell LW. The role of alcoholism in hepatic iron storage disease. Ann. NY Acad. Sci. 1975; 252: 124-34.
91. 91 Bomford A, Williams R. Long term results of venesection therapy in idiopathic hemochromatosis. Q. J. Med. 1976; 180: 611-23.
92. 92 Milder MS, Cook JD, Stray S, Finch CA. Idiopathic haemochromatosis, an interim report. Medicine 1980; 59: 34-49.
93. 93 Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: Prevalence and clinical consequences among homozygous siblings. Hepatology 1996; 23: 724-7.
94. 94 Grove J, Daly AK, Burt AD, Guzail M, Bassendine MF, Day CP. HLA-H mutations, hepatic iron content and risk of advanced liver disease in alcoholics. Hepatology 1997; 26: 275A.
95. 95 Gordeuk VR, Devee Boyd R, Brittenham G. Dietary iron overload persists in rural Sub-Saharan Africa. Lancet 1986; 1: 1310-13.
96. 96 Gordeuk VR, Mukiibi J, Hastedt SJ. Iron overload in Africa. N. Engl. J. Med. 1992; 326: 95-100.
97. 97 Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am. J. Med. 1995; 99: 616-23.
98. 98 Wurapa RK, Gordeuk VR, Brittenham GM, Khiyami A, Schechter GP, Edwards CQ. Primary iron overload in African Americans. JAMA 1996; 101: 9-18.
99. 99 Farrell FJ, Nguyen M, Woodley S et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology 1994; 20: 404-10.
100. 100 Tung BY, Tabasco-Minguillan J, Bacon BR et al. Long-term follow-up after liver transplantation for hereditary hemochromatosis. Hepatology 1997; 26: 343A.
101. 101 Ludwig J, Hashimoto E, Porayko MK, Moyer TP. Hemosiderosis in cirrhosis: A study of 447 native livers. Gastroenterology 1997; 112: 882-8.
102. 102 Pascoe A, Kerlin P, Steadman C et al. Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation. Gastroenterology 1998; 114: 10 449.
103. 103 De Knegt RJ, Hepkema BG, Slooff MJH, Jansen PLM. Hemochromatosis gene mutations in liver transplant patients. Hepatology 1997; 26: 499A.
104. 104 Ishii H, Kurose I, Kato S. Pathogenesis of alcoholic liver disease with particular emphasis on oxidative stress. J. Gastroenterol. Hepatol. 1997; 12 (Suppl.): S272-82.
105. 105 Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic. Biol. Med. 1992; 12: 417-27.
106. 106 Stal P, Hultcrantz R. Iron increases ethanol toxicity in rat liver. J. Hepatol. 1993; 17: 108-15.
107. 107 Stal P, Johansson I, Ingelman-Sundberg M, Hagen K, Hultcrantz R. Hepatotoxicity induced by iron overload and alcohol: Studies on the role of chelatable iron, cytochrome P450, 2E1 and lipid peroxidation. J. Hepatol. 1996; 25: 538-46.
108. 108 Olynyk J, Hall P, Reed W, Williams P, Kerr R, Mackinnon M. A long term study of the interaction of iron and alcohol in an animal model of iron overload. J. Hepatol. 1995; 22: 671-6.
109. 109 Tsukamoto H, Horne W, Seiichiro K et al. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 1995; 96: 620-30.
110. 110 Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-9.
111. 111 Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990; 12: 20-5.
112. 112 Sallie RW, Reed WD, Shilkin KB. Conformation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 1991; 32: 207-10.
113. 113 Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology 1975; 68: 525-33.
114. 114 Brissot P, Bourel M, Herry D et al. Assessment of liver iron content in 271 patients: A re-evaluation of direct and indirect methods. Gastroenterology 1981; 80: 557-65.
115. 115 Kristenson H, Fex G, Trell E. Serum ferritin, gamma glutamyl-transferase and alcohol consumption in healthy middle-aged men. Drug Alcohol Depend. 1981; 8: 43-50.
116. 116 Lundin L, Hallgren R, Birgegard G, Wide L. Serum ferritin in alcoholics and the relation to liver damage, iron status and erythropoietic activity. Acta Psychiatr. Scand. 1981; 209: 327-31.
117. 117 Valimaki M, Harkonen M, Ylikahri R. Serum ferritin and iron levels in chronic male alcoholics before and after ethanol withdrawal. Alcohol Alcohol. 1983; 18: 255-60.
118. 118 Chick J, Pikkarainen J, Plant M. Serum ferritin as a marker of alcohol consumption in working men. Alcohol Alcohol. 1987; 22: 75-7.
119. 119 Bell H, Skinningsrud A, Raknerud N, Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver disease. J. Int. Med. 1994; 236: 315-22.
120. 120 Moirand R, Lescoat G, Delamaire D et al. Increase in glycosylated and nonglycosylated serum ferritin in chronic alcoholism and their evolution during alcohol withdrawal. Alcohol. Clin. Exp. Res. 1991; 15: 963-9.
121. 121 Leggett BA, Brown NN, Bryant SJ, Duplock L, Powell LW, Halliday JW. Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin. Chem. 1990; 36: 1350-5.
122. 122 Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N. Engl. J. Med. 1974; 290: 1213-16.
123. 123 Meyer TE, Kassianides C, Bothwell TH, Green A. Effects of heavy alcohol consumption on serum ferritin concentrations. S. Afr. Med. J. 1984; 66: 573-5.
124. 124 Batey RG, Chung Fong L, Shamir S, Sherlock S. A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig. Dis. Sci. 1980; 25: 340-6.
125. 125 Brissot P, Wright TL, Ma W-L, Weisiger RA. Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J. Clin. Invest. 1985; 76: 1463-70.
126. 126 Dadone MM, Kushner JP, Edwards CQ, Bishop DT, Skolnick MH. Hereditary haemochromatosis. Analysis of the laboratory expression of the disease by genotype in 18 pedigrees. Am. J. Clin. Pathol. 1982; 78: 196-207.
127. 127 Cartwright GE, Edwards CQ, Kravitz K et al. Hereditary hemochromatosis: Phenotypic expression of the disease. N. Engl. J. Med. 1979; 301: 175-9.
128. 128 Bassett ML, Halliday JW, Powell LW. HLA typing in idiopathic haemochromatosis: Distinction between homozygotes and heterozygotes with biochemical expression. Hepatology 1981; 1: 120-6.
129. 129 Regoeczi E, Chindemi PA, Debanne MT. Transferrin glycans: A possible link between alcoholism and hepatic siderosis. Alcohol. Clin. Exp. Res. 1984; 8: 287-92.
130. 130 Dekker CJ, Kroos MJ, van der Heul C, van Eijk HG. Uptake of sialo and asialo transferrins by isolated rat hepatocytes. Comparison of a heterologous and homologous system. Int. J. Biochem. 1985; 17: 701-6.
131. 131 Young SP, Bomford A, Williams R. Dual pathways for the uptake of rat asialotransferrin by rat hepatocytes. J. Biol. Chem. 1983; 258: 4972-6.
132. 132 Regoeczi E, Koj A. Diacytosis of human asialotransferrin type 3 in the rat liver is due to the sequential engagement of two receptors. Exp. Cell. Res. 1985; 160: 1-8.
133. 133 Fletcher LM. Alcohol and iron: One glass of red or more? J. Gastroenterol. Hepatol. 1996; 11: 1039-41.
134. 134 Bothwell TH, Charlton RW, Cook JD, Finch CA. Alcohol, iron and liver disease. In: Bothwell TH, Charlton RW, Cook JD, Finch CA, eds. Iron Metabolism in Man. Oxford: Blackwell Scientific Publications, 1979; 156-74.
135. 135 Celada A, Rudolf H, Donath A. Effect of a single ingestion of alcohol on iron absorption. Am. J. Hematol. 1978; 5: 225-37.
136. 136 Duane P, Raja KB, Simpson RJ, Peters TJ. Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol. 1992; 27: 539-44.
137. 137 Edwards CQ, Griffen LM, Goldgar DE, Skolnick MH, Kushner JP. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Lancet 1985; ii: 229-33.
138. 138 Beaumont C, Fauchet R, Phung LN, de Verneuil H, Gueguen M, Nordmann Y. Porphyria cutanea tarda and HLA-linked hemochromatosis: Evidence against a systemic association. Gastroenterology 1987; 92: 1833-8.
139. 139 Fargion S, Francanzano AL, Romano R et al. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: Possible explanations for iron overload. J. Hepatol. 1996; 24: 564-9.
140. 140 Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.
141. 141 Stuart KA, Busfield F, Jazwinska EC et al. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J. Hepatol. 1998; 28: 404-9.
142. 142 George DK, Goldwurm S, Macdonald GA et al. Increased hepatic iron stores in non alcoholic steatohepatitis are associated with the hemochromatosis mutation and increased liver damage. Gastroenterology 1998; 114: 311-18.
143. 143 Bacon BR, Fried MW, DiBisceglie AM. A 39-year-old man with chronic hepatitis, elevated serum ferritin levels and a family history of hemochromatosis. Semin. Liver Dis. 1993; 13: 101-5.
144. 144 Piperno A, Sampietro M, D'Alba R et al. Iron stores, response to alpha-interferon therapy and effects of iron depletion in chronic hepatitis C. Liver 1996; 16: 248-54.
145. 145 Ikura Y, Morimoto H, Johmura H, Fukui M, Sakurai M. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am. J. Gastroenterol. 1996; 91: 1367-73.
146. 146 Olynyk JK, Reddy KR, Di-Bisceglie AM et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995; 108: 1104-9.
147. 147 Gehrke SG, Riedel HD, Fitcher BA, Goeser T, Stremmel W, Kallinowski B. Prevalence of mutations in the hemochromatosis gene HLA-H in patients with chronic hepatitis C. Influence on histological activity, iron metabolism and response to interferon therapy. Hepatology 1997; 26: 410A.
148. 148 Smith BC, Grove J, Guzail MA et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695-700.
149. 149 Okuda K, Ohnishi K. Distinction between haemochromatosis and alcoholic siderosis. In: Hall P, ed. Alcoholic Liver Disease: Pathology and Pathogenesis. London: Edward Arnold, 1995; 147-59.
150. 150 Farinati F, Cardin R, De Maria N et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 1995; 22: 449-56.
151. 151 Izumi N, Enomoto N, Uchihara M et al. Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus. Dig. Dis. Sci. 1996; 41: 989-94.
152. 152 Farinati F, Cardin R, D'Errico A et al. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: The role of etiology, disease activity, iron and lipid peroxidation. Hepatology 1996; 23: 1468-75.
153. 153 Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998; 27: 914-19.
154. 154 Burt MJ, Cooksley WG. The influence of iron on chronic hepatitis C. J. Gastroenterol. Hepatol. 1998; 13: 330-3.
155. 155 Powell LW. Changing concepts in haemochromatosis. Postgrad. Med. J. 1970; 46: 200-9.
156. 156 Darnis F, Masse A, Breaute C et al. Les hemochromatoses. Aspects actuels du traitment des hemochromatoses a propos de 100 obsevations. Ann. Intern. Med. 1971; 122: 1193-210.
157. 157 Grace ND, Greenberg MS. Phlebotomy in the treatment of iron overload: A controlled trial (a preliminary report). Gastroenterology 1971; 60: 744.